The Gross Law Firm issues the following notice to shareholders of Fiserv, Inc. (NYSE: FI). https://mma.prnewswire.com/media/2280333/The_Gross_Law_Firm_Logo.jpg Shareholders who purchased shares of FI during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: Fiserv, Inc. […]

The Gross Law Firm issues the following notice to shareholders of RxSight, Inc. (NASDAQ: RXST). https://mma.prnewswire.com/media/2280333/The_Gross_Law_Firm_Logo.jpg Shareholders who purchased shares of RXST during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE:https://securitiesclasslaw.com/securities/rxsight-inc-loss-submission-form/?id=166334&from=4 CLASS PERIOD:

The Gross Law Firm issues the following notice to shareholders of Replimune Group, Inc. (NASDAQ: REPL). https://mma.prnewswire.com/media/2280333/The_Gross_Law_Firm_Logo.jpg Shareholders who purchased shares of REPL during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: Replimune

The Gross Law Firm issues the following notice to shareholders of Alto Neuroscience, Inc. (NYSE: ANRO). https://mma.prnewswire.com/media/2280333/The_Gross_Law_Firm_Logo.jpg Shareholders who purchased shares of ANRO during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: Alto

The Gross Law Firm issues the following notice to shareholders of Neogen Corporation (NASDAQ: NEOG). https://mma.prnewswire.com/media/2280333/The_Gross_Law_Firm_Logo.jpg Shareholders who purchased shares of NEOG during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: Neogen Corporation

The Gross Law Firm issues the following notice to shareholders of Capricor Therapeutics, Inc. (NASDAQ: CAPR). https://mma.prnewswire.com/media/2280333/The_Gross_Law_Firm_Logo.jpg Shareholders who purchased shares of CAPR during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: Capricor

The Gross Law Firm issues the following notice to shareholders of Unicycive Therapeutics, Inc. (NASDAQ: UNCY). https://mma.prnewswire.com/media/2280333/The_Gross_Law_Firm_Logo.jpg Shareholders who purchased shares of UNCY during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: Unicycive

The Gross Law Firm issues the following notice to shareholders of Biohaven Ltd. (NYSE: BHVN). https://mma.prnewswire.com/media/2280333/The_Gross_Law_Firm_Logo.jpg Shareholders who purchased shares of BHVN during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: Biohaven Ltd.

MarketNewsUpdates News Commentary The global Diagnostic Biomarker market is experiencing unprecedented growth and is projected to continue to see substantial growth in years to come. A recentreportfrom the (NIH) National Library of Medicine discussed the AI-Assisted Biomarker, said that: “Recently, advancements in healthcare digitization and personalized treatments have led to groundbreaking developments. Utilization of AI

Purcell & Lefkowitz LLP announces that it is investigating Blue Ridge Bankshares, Inc. (NYSE American: BRBS) on behalf of the company's shareholders. The investigation seeks to determine whether Blue RidgeBankshares's directors breached their fiduciary duties in connection with recent corporate actions. https://mma.prnewswire.com/media/2264679/PLLogo1_Logo.jpg If you are a shareholder of Blue Ridge Bankshares, Inc. and are interested